People with treatment-resistant depression can find relief from their debilitating symptoms at the New Life Ketamine Clinic. The healthcare providers offer ketamine infusion therapy for patients that have not found recovery from their depression symptoms through traditional forms of medicine.
New Life Ketamine Clinic is led by Dr. Curran L. Jones. Dr. Jones has been an Anesthesiology Specialist for almost two decades and believes in the power of cutting-edge therapy for depression symptoms. He and his team are passionate about helping their patients regain control of their health and live the lives they deserve.
Each patient receives a tailored plan to help address their individual needs in a way that provides long-lasting and effective healing. By utilizing ketamine therapy, the staff at the healing center can truly offer their patients a chance at a new life.
Before beginning infusion therapy, an initial consultation will be held to determine if ketamine is an appropriate course of treatment for you. A mental health screening and comprehensive assessment by a doctor will be conducted. A general medical assessment and physical exam are also required to ensure there are no underlying medical conditions that may prohibit the use of ketamine. Urine drug screenings will be given to rule out the use of illicit substances.
Once approved, most patients receive a series of 6 infusions over the course of a 2-week period. Each infusion typically takes approximately 40 minutes, with a total time spent at the facility of 1 – 1.5 hours per session. Patients can typically tell if ketamine infusions are working for them after only one or two treatments.
If patients respond positively to ketamine, a booster infusion is usually required 6 – 8 weeks following the initial series to keep symptoms at bay, then every 6 months or so after that.
All booster infusions are given as single infusions rather than a series of 6 as in done in the initial phase. Research has continually shown that this is the best method to employ to give patients the greatest chance of symptom relief, with an over 70% success rate in clinical trials.